We are an interdisciplinary team based at the University of Manchester and Salford Royal NHS Foundation Trust. We have an active programme of clinical and scientific research investigating the pathophysiology, epidemiology, measurement and treatment of systemic sclerosis and primary Raynaud's phenomenon.
See: About us for more about the research group.
Our current research is made possible by funding from Scleroderma & Raynaud's UK, Arthritis Research UK, the Wellcome Trust and EULAR.
What are systemic sclerosis and Raynaud's phenomenon?
Systemic sclerosis (also known as scleroderma) is a rare multi-system connective tissue disease. It is characterised by excessive collagen deposition (leading to fibrosis), vascular abnormality and immune dysfunction.
Raynaud's phenomenon (episodic colour changes of the fingers, usually in response to cold exposure) is very common. It is a key feature of systemic sclerosis but, for most people, it occurs in the absence of any underlying condition in which case it is termed primary Raynaud's phenomenon.
Taking part and volunteering
People affected by scleroderma and Raynaud's phenomenon are asked to take part in our research. We also need healthy people to volunteer for many of our imaging studies.
See: Volunteering opportunities for more information
Living with scleroderma and Raynaud's
To find out more, see: Living with scleroderma and Raynaud's
Get in touch